FDA recall D-0375-2021

Teva Pharmaceuticals USA · Class II · drug

Product

Haloperidol Decanoate Injection, USP 50 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, Teva Pharmaceuticals, USA, Inc., North Wales, PA NDC 00703-7121-03

Reason for recall

Lack of Assurance of Sterility

Distribution

Product was distributed nationwide.

Key facts

Status
Terminated
Initiation date
2021-04-26
Report date
2021-05-26
Termination date
2024-06-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0375-2021